Free Trial
→ [Action Required] Claim Your FREE IRS Loophole Guide (From Colonial Metals) (Ad) Buy ALHC Stock  Free ALHC Stock Alerts

Alignment Healthcare (ALHC) Financials

Alignment Healthcare logo
$19.76 +0.33 (+1.69%)
As of 11:27 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Alignment Healthcare

Annual Income Statements for Alignment Healthcare

This table shows Alignment Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -45 -23 -195 -150 -148 -128
Consolidated Net Income / (Loss)		 -45 -23 -195 -150 -148 -128
Net Income / (Loss) Continuing Operations		 -45 -23 -195 -150 -148 -128
Total Pre-Tax Income 		-45 -23 -195 -149 -148 -128
Total Operating Income		 -29 -5.26 -178 -129 -128 -102
Total Gross Profit		 757 959 1,168 1,434 1,824 2,704
Total Revenue		 757 959 1,168 1,434 1,824 2,704
Operating Revenue		 757 959 1,168 1,434 1,824 2,704
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 786 964 1,346 1,563 1,951 2,805
Selling, General & Admin Expense		 110 156 291 296 307 371
Depreciation Expense		 15 15 16 17 21 27
Other Operating Expenses / (Income)		 661 793 1,039 1,250 1,623 2,407
Total Other Income / (Expense), net		 -15 -18 -17 -20 -21 -27
Interest Expense		 15 17 17 20 21 27
Income Tax Expense		 0.00 0.00 0.00 0.34 -0.02 0.02
Net Income / (Loss) Attributable to Noncontrolling Interest		 - 0.00 0.00 -0.09 -0.16 -0.04
Basic Earnings per Share		 ($0.33) ($0.15) ($1.14) ($0.83) ($0.79) ($0.67)
Weighted Average Basic Shares Outstanding		 135.86M 152.13M 171.96M 181.21M 186.21M 190.79M
Diluted Earnings per Share		 ($0.33) ($0.15) ($1.14) ($0.83) ($0.79) ($0.67)
Weighted Average Diluted Shares Outstanding		 135.86M 152.13M 171.96M 181.21M 186.21M 190.79M
Weighted Average Basic & Diluted Shares Outstanding		 135.86M 152.13M 171.96M 181.21M 188.98M 191.83M

Quarterly Income Statements for Alignment Healthcare

This table shows Alignment Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 -40 -57 -37 -28 -35 -47 -47 -24 -26 -31
Consolidated Net Income / (Loss)		 -40 -57 -37 -28 -35 -47 -47 -24 -26 -31
Net Income / (Loss) Continuing Operations		 -40 -58 -37 -28 -35 -47 -47 -24 -26 -31
Total Pre-Tax Income 		-40 -57 -37 -28 -35 -47 -47 -24 -26 -31
Total Operating Income		 -33 -52 -32 -24 -30 -42 -41 -18 -20 -23
Total Gross Profit		 360 362 439 462 457 465 629 681 692 701
Total Revenue		 360 362 439 462 457 465 629 681 692 701
Operating Revenue		 360 362 439 462 457 465 629 681 692 701
Total Operating Expenses		 394 414 472 486 486 507 670 700 712 724
Selling, General & Admin Expense		 76 83 70 70 83 84 91 88 91 102
Depreciation Expense		 4.46 4.69 4.92 5.20 5.50 5.80 5.98 6.49 7.64 6.76
Other Operating Expenses / (Income)		 313 326 396 411 398 418 573 605 613 615
Total Other Income / (Expense), net		 -6.67 -5.43 -4.88 -4.83 -5.47 -6.05 -5.47 -5.60 -6.94 -8.56
Interest Expense		 6.80 4.79 5.02 5.26 5.47 5.48 5.43 5.69 6.94 8.51
Income Tax Expense		 0.17 0.17 0.00 0.00 0.00 -0.02 0.00 0.02 -0.01 0.01
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 -0.09 -0.09 -0.02 -0.03 -0.02 -0.05 0.01 -0.02 0.03
Basic Earnings per Share		 ($0.22) ($0.32) ($0.20) ($0.15) ($0.19) ($0.25) ($0.25) ($0.13) ($0.14) ($0.15)
Weighted Average Basic Shares Outstanding		 182.12M 181.21M 183.11M 185.99M 187.33M 186.21M 189.01M 190.89M 191.36M 190.79M
Diluted Earnings per Share		 ($0.22) ($0.32) ($0.20) ($0.15) ($0.19) ($0.25) ($0.25) ($0.13) ($0.14) ($0.15)
Weighted Average Diluted Shares Outstanding		 182.12M 181.21M 183.11M 185.99M 187.33M 186.21M 189.01M 190.89M 191.36M 190.79M
Weighted Average Basic & Diluted Shares Outstanding		 0.00 181.21M 183.11M 185.99M 0.00 188.98M 191.20M 191.30M 191.70M 191.83M

Annual Cash Flow Statements for Alignment Healthcare

This table details how cash moves in and out of Alignment Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 52 121 261 -57 -206 230
Net Cash From Operating Activities		 9.21 7.56 -79 -45 -59 35
Net Cash From Continuing Operating Activities		 9.21 7.56 -79 -45 -59 35
Net Income / (Loss) Continuing Operations		 -45 -23 -195 -150 -148 -128
Consolidated Net Income / (Loss)		 -45 -23 -195 -150 -148 -128
Depreciation Expense		 17 15 16 17 22 27
Amortization Expense		 1.95 2.19 2.25 1.85 1.25 1.29
Non-Cash Adjustments To Reconcile Net Income		 6.41 9.58 114 72 64 74
Changes in Operating Assets and Liabilities, net		 29 3.25 -16 13 2.03 61
Net Cash From Investing Activities		 -10 -16 -21 -28 -147 39
Net Cash From Continuing Investing Activities		 -10 -16 -21 -28 -147 39
Purchase of Property, Plant & Equipment		 -10 -16 -18 -28 -36 -41
Purchase of Investments		 -0.32 -1.58 -2.48 -2.83 -379 -82
Sale of Property, Plant & Equipment		 0.00 0.10 - 0.00 0.00 0.01
Sale and/or Maturity of Investments		 0.33 0.83 1.43 2.43 268 163
Net Cash From Financing Activities		 53 130 360 17 0.11 156
Net Cash From Continuing Financing Activities		 53 130 360 17 0.11 156
Repayment of Debt		 -0.85 0.00 0.00 -148 0.00 -224
Payment of Dividends		 0.00 0.00 0.00 -0.10 0.00 0.00
Issuance of Debt		 55 0.00 0.00 165 0.00 380
Issuance of Common Equity		 0.50 135 391 0.07 0.11 0.02
Other Financing Activities, net		 - - - 0.00 0.00 -0.20
Cash Interest Paid		 9.53 11 11 22 19 22

Quarterly Cash Flow Statements for Alignment Healthcare

This table details how cash moves in and out of Alignment Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 114 -158 -25 11 -3.62 -188 36 100 1.63 92
Net Cash From Operating Activities		 105 -149 85 37 5.99 -187 -6.24 24 26 -8.71
Net Cash From Continuing Operating Activities		 105 -149 85 37 5.99 -187 -6.24 24 26 -8.71
Net Income / (Loss) Continuing Operations		 -40 -57 -37 -28 -35 -47 -47 -24 -26 -31
Consolidated Net Income / (Loss)		 -40 -57 -37 -28 -35 -47 -47 -24 -26 -31
Depreciation Expense		 4.51 4.75 4.98 5.26 5.56 5.86 6.03 6.54 7.69 6.81
Amortization Expense		 0.48 0.23 0.31 0.43 0.30 0.22 0.52 0.09 0.37 0.32
Non-Cash Adjustments To Reconcile Net Income		 8.30 19 22 12 12 17 20 17 17 19
Changes in Operating Assets and Liabilities, net		 132 -117 95 47 23 -164 13 24 27 -3.94
Net Cash From Investing Activities		 -8.13 -8.11 -110 -26 -9.61 -1.02 43 27 -25 -5.92
Net Cash From Continuing Investing Activities		 -8.13 -8.11 -110 -26 -9.61 -1.02 43 27 -25 -5.92
Purchase of Property, Plant & Equipment		 -7.83 -8.11 -7.29 -8.56 -9.55 -11 -11 -12 -9.28 -9.28
Purchase of Investments		 -1.73 - -104 -53 -125 -97 -22 -18 -36 -6.68
Sale and/or Maturity of Investments		 1.43 - 1.10 35 125 107 75 57 20 10
Net Cash From Financing Activities		 17 -0.53 0.03 0.03 - 0.05 -0.34 49 - 107
Net Cash From Continuing Financing Activities		 17 -0.53 0.03 0.03 - 0.05 -0.34 49 - 107
Repayment of Debt		 - -0.60 - - - - - - - -223
Issuance of Debt		 - - - - - - - - - 330
Other Financing Activities, net		 - - 0.00 - - - -0.35 - - 0.16
Cash Interest Paid		 17 - 4.28 4.71 4.96 5.22 5.18 5.07 5.36 6.56

Annual Balance Sheets for Alignment Healthcare

This table presents Alignment Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Total Assets		 339 631 634 592 782
Total Current Assets		 265 553 545 484 662
Cash & Equivalents		 207 467 410 203 433
Short-Term Investments		 - - 0.00 116 38
Accounts Receivable		 40 59 93 120 154
Prepaid Expenses		 17 28 42 45 37
Plant, Property, & Equipment, net		 27 30 37 52 67
Total Noncurrent Assets		 47 48 52 56 53
Goodwill		 35 35 35 35 35
Intangible Assets		 - - 5.48 5.25 4.55
Other Noncurrent Operating Assets		 12 13 12 16 14
Total Liabilities & Shareholders' Equity		 339 631 634 592 782
Total Liabilities		 308 325 395 434 681
Total Current Liabilities		 153 167 230 263 352
Accounts Payable		 16 17 32 24 22
Current Employee Benefit Liabilities		 - - - 34 40
Other Current Liabilities		 113 126 170 205 290
Total Noncurrent Liabilities		 154 158 165 171 329
Long-Term Debt		 144 151 161 162 321
Other Noncurrent Operating Liabilities		 10 6.98 3.70 8.97 7.84
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 31 306 239 158 101
Total Preferred & Common Equity		 31 306 238 157 100
Preferred Stock		 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 31 306 238 157 100
Common Stock		 410 889 970 1,037 1,108
Retained Earnings		 -380 -583 -732 -880 -1,008
Noncontrolling Interest		 0.00 0.02 1.18 1.13 1.10

Quarterly Balance Sheets for Alignment Healthcare

This table presents Alignment Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets		 778 762 784 771 633 716 692
Total Current Assets		 692 671 684 667 521 599 574
Cash & Equivalents		 567 384 395 392 239 339 340
Short-Term Investments		 - 103 122 124 63 25 41
Accounts Receivable		 88 125 89 106 165 183 139
Prepaid Expenses		 36 58 77 46 54 52 54
Plant, Property, & Equipment, net		 36 40 43 47 57 62 65
Total Noncurrent Assets		 50 51 57 57 55 55 54
Goodwill		 38 40 40 40 35 35 35
Intangible Assets		 - - - - 5.22 5.20 4.55
Other Noncurrent Operating Assets		 12 11 17 17 15 15 15
Total Liabilities & Shareholders' Equity		 778 762 784 771 633 716 692
Total Liabilities		 505 538 572 581 501 591 577
Total Current Liabilities		 340 374 402 410 331 372 358
Short-Term Debt		 - - - - - - 1.61
Accounts Payable		 21 23 21 25 23 23 25
Accrued Expenses		 31 25 26 35 32 33 34
Other Current Liabilities		 171 186 207 203 276 315 297
Total Noncurrent Liabilities		 165 164 171 171 170 220 219
Long-Term Debt		 161 161 161 162 162 212 210
Other Noncurrent Operating Liabilities		 4.46 2.50 9.21 9.32 8.44 8.18 8.19
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 272 224 211 190 132 125 116
Total Preferred & Common Equity		 272 223 210 189 131 124 115
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 272 223 210 189 131 124 115
Common Stock		 947 992 1,008 1,022 1,058 1,074 1,092
Retained Earnings		 -675 -770 -798 -833 -927 -951 -977
Noncontrolling Interest		 0.00 1.12 1.13 1.10 1.09 1.09 1.08

Annual Metrics and Ratios for Alignment Healthcare

This table displays calculated financial ratios and metrics derived from Alignment Healthcare's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 26.72% 21.74% 22.81% 27.16% 48.25%
EBITDA Growth		 0.00% 203.14% -1,468.64% 31.50% 4.03% 30.22%
EBIT Growth		 0.00% 79.91% -2,866.52% 27.67% 0.64% 20.55%
NOPAT Growth		 0.00% 82.15% -3,283.47% 27.76% 0.64% 20.55%
Net Income Growth		 0.00% 48.75% -751.81% 23.37% 0.98% 13.57%
EPS Growth		 0.00% 54.55% -660.00% 27.19% 4.82% 15.19%
Operating Cash Flow Growth		 0.00% -17.89% -1,141.87% 42.33% -30.29% 158.75%
Free Cash Flow Firm Growth		 0.00% 0.00% -610.46% 38.46% -10.21% 78.22%
Invested Capital Growth		 0.00% 0.00% 69.49% 5.84% 111.41% -4,627.86%
Revenue Q/Q Growth		 0.00% 0.00% -13.97% 4.64% 6.02% 9.56%
EBITDA Q/Q Growth		 0.00% 0.00% -10.85% -9.07% 9.71% 25.71%
EBIT Q/Q Growth		 0.00% 0.00% -9.63% -7.84% 7.39% 16.02%
NOPAT Q/Q Growth		 0.00% 0.00% -9.65% -7.20% 7.39% 16.02%
Net Income Q/Q Growth		 0.00% 0.00% -8.78% -6.52% 6.18% 11.21%
EPS Q/Q Growth		 0.00% 0.00% -5.56% -7.79% 8.14% 12.99%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -34.00% -161.64% -182.06% 124.15%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -474.76% -49.38% 88.88%
Invested Capital Q/Q Growth		 0.00% 0.00% 62.47% 93.06% 100.65% 9.53%
Profitability Metrics		 - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -1.49% 1.22% -13.66% -7.62% -5.75% -2.71%
Operating Margin		 -3.90% -0.55% -15.25% -8.97% -7.01% -3.76%
EBIT Margin		 -3.94% -0.63% -15.23% -8.97% -7.01% -3.76%
Profit (Net Income) Margin		 -5.91% -2.39% -16.72% -10.43% -8.13% -4.74%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.23% 99.99% 100.02%
Interest Burden Percent		 149.93% 382.42% 109.81% 116.06% 115.94% 126.09%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -74.89% -116.01% -54.88% -74.58% -98.89%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% -9,369.88% 0.00%
Operating Return on Assets (OROA)		 0.00% -1.77% -36.69% -20.34% -20.86% -14.78%
Return on Assets (ROA)		 0.00% -6.77% -40.29% -23.66% -24.18% -18.64%
Return on Common Equity (ROCE)		 0.00% -74.89% -116.01% -54.76% -74.14% -98.04%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -74.89% -63.81% -62.84% -94.41% -128.26%
Net Operating Profit after Tax (NOPAT)		 -21 -3.68 -125 -90 -89 -71
NOPAT Margin		 -2.73% -0.38% -10.67% -6.28% -4.91% -2.63%
Net Nonoperating Expense Percent (NNEP)		 0.00% -60.95% -37.26% -21.11% -28.94% -37.22%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -22.50% -27.97% -16.83%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 14.55% 16.30% 24.92% 20.61% 16.86% 13.74%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 103.90% 100.55% 115.25% 108.97% 107.01% 103.76%
Earnings before Interest and Taxes (EBIT)		 -30 -6.00 -178 -129 -128 -102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -11 12 -160 -109 -105 -73
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 15.99 8.60 9.25 10.37 21.60
Price to Tangible Book Value (P/TBV)		 0.00 0.00 9.72 11.13 13.93 35.66
Price to Revenue (P/Rev)		 0.65 0.51 2.25 1.54 0.89 0.80
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 1,381.12 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.44 1.98 1.36 0.81 0.74
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 36.58 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 56.40 0.00 0.00 0.00 57.76
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 14.78 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 4.71 0.49 0.67 1.02 3.18
Long-Term Debt to Equity		 0.00 4.71 0.49 0.67 1.02 3.18
Financial Leverage		 0.00 -2.06 -1.13 -1.04 -1.02 -1.18
Leverage Ratio		 0.00 11.06 2.88 2.32 3.08 5.30
Compound Leverage Factor		 0.00 42.29 3.16 2.69 3.58 6.69
Debt to Total Capital		 0.00% 82.49% 32.98% 40.21% 50.58% 76.10%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 82.49% 32.98% 40.21% 50.58% 76.10%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.29% 0.35% 0.26%
Common Equity to Total Capital		 0.00% 17.51% 67.01% 59.50% 49.06% 23.64%
Debt to EBITDA		 0.00 12.37 -0.94 -1.47 -1.54 -4.39
Net Debt to EBITDA		 0.00 -5.42 1.98 2.27 1.50 2.04
Long-Term Debt to EBITDA		 0.00 12.37 -0.94 -1.47 -1.54 -4.39
Debt to NOPAT		 0.00 -39.13 -1.21 -1.79 -1.81 -4.52
Net Debt to NOPAT		 0.00 17.14 2.53 2.76 1.75 2.10
Long-Term Debt to NOPAT		 0.00 -39.13 -1.21 -1.79 -1.81 -4.52
Altman Z-Score		 0.00 2.55 5.22 3.92 2.99 3.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.22% 0.58% 0.86%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.00 1.72 3.31 2.37 1.84 1.88
Quick Ratio		 0.00 1.61 3.14 2.18 1.67 1.78
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 29 -147 -91 -100 -22
Operating Cash Flow to CapEx		 89.88% 48.44% -429.06% -163.31% -164.43% 83.98%
Free Cash Flow to Firm to Interest Expense		 0.00 1.70 -8.44 -4.42 -4.70 -0.82
Operating Cash Flow to Interest Expense		 0.62 0.45 -4.52 -2.22 -2.79 1.31
Operating Cash Flow Less CapEx to Interest Expense		 -0.07 -0.48 -5.57 -3.58 -4.48 -0.25
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.00 2.83 2.41 2.27 2.98 3.94
Accounts Receivable Turnover		 0.00 23.90 23.67 18.95 17.15 19.76
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 35.34 40.62 42.48 40.95 45.42
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 15.27 15.42 19.27 21.28 18.47
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 15.27 15.42 19.27 21.28 18.47
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.00 -33 -9.93 -9.35 1.07 -48
Invested Capital Turnover		 0.00 -58.97 -55.01 -148.85 -440.54 -114.56
Increase / (Decrease) in Invested Capital		 0.00 -33 23 0.58 10 -49
Enterprise Value (EV)		 0.00 426 2,317 1,955 1,472 2,008
Market Capitalization		 490 490 2,633 2,202 1,628 2,157
Book Value per Share		 $0.00 $0.20 $1.63 $1.27 $0.83 $0.52
Tangible Book Value per Share		 $0.00 ($0.03) $1.45 $1.06 $0.62 $0.32
Total Capital		 0.00 175 457 400 320 422
Total Debt		 0.00 144 151 161 162 321
Total Long-Term Debt		 0.00 144 151 161 162 321
Net Debt		 0.00 -63 -316 -249 -157 -149
Capital Expenditures (CapEx)		 10 16 18 28 36 41
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -96 -81 -95 -98 -161
Debt-free Net Working Capital (DFNWC)		 0.00 111 386 315 221 310
Net Working Capital (NWC)		 0.00 111 386 315 221 310
Net Nonoperating Expense (NNE)		 24 19 71 60 59 57
Net Nonoperating Obligations (NNO)		 0.00 -63 -316 -249 -157 -149
Total Depreciation and Amortization (D&A)		 19 18 18 19 23 28
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -10.02% -6.94% -6.62% -5.39% -5.95%
Debt-free Net Working Capital to Revenue		 0.00% 11.60% 33.02% 21.94% 12.09% 11.46%
Net Working Capital to Revenue		 0.00% 11.60% 33.02% 21.94% 12.09% 11.46%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($1.14) ($0.83) ($0.79) ($0.67)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 187.07M 187.28M 186.21M 190.79M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($1.14) ($0.83) ($0.79) ($0.67)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 187.07M 187.28M 186.21M 190.79M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($1.14) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 171.96M 181.21M 188.98M 191.83M
Normalized Net Operating Profit after Tax (NOPAT)		 -21 -3.68 -125 -90 -89 -71
Normalized NOPAT Margin		 -2.73% -0.38% -10.67% -6.28% -4.91% -2.63%
Pre Tax Income Margin		 -5.91% -2.39% -16.72% -10.41% -8.13% -4.74%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 -2.00 -0.35 -10.20 -6.28 -6.02 -3.82
NOPAT to Interest Expense		 -1.39 -0.22 -7.15 -4.40 -4.21 -2.68
EBIT Less CapEx to Interest Expense		 -2.69 -1.28 -11.25 -7.64 -7.72 -5.38
NOPAT Less CapEx to Interest Expense		 -2.07 -1.14 -8.20 -5.75 -5.91 -4.23
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% -0.07% 0.00% 0.00%
Augmented Payout Ratio		 -4.43% -21.27% -15.61% -0.07% 0.00% 0.00%

Quarterly Metrics and Ratios for Alignment Healthcare

This table displays calculated financial ratios and metrics derived from Alignment Healthcare's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 22.79% 21.30% 27.10% 26.17% 26.74% 28.63% 43.14% 47.34% 51.61% 50.68%
EBITDA Growth		 22.91% -21.89% 15.05% -1,150.04% 15.55% 23.95% -27.84% 33.52% 51.99% 56.96%
EBIT Growth		 19.62% -20.11% 11.16% -274.33% 10.59% 19.56% -27.19% 21.27% 34.39% 46.21%
NOPAT Growth		 19.40% -19.88% 10.93% -255.88% 10.94% 19.56% -26.52% 22.30% 34.39% 46.21%
Net Income Growth		 12.16% -19.15% 8.44% -146.06% 12.85% 17.13% -24.63% 15.76% 24.65% 34.23%
EPS Growth		 15.38% -23.08% 13.04% -150.00% 13.64% 21.88% -25.00% 13.33% 26.32% 40.00%
Operating Cash Flow Growth		 714.00% -395.33% 831.31% 259.06% -94.30% -25.59% -107.33% -36.71% 337.08% 95.35%
Free Cash Flow Firm Growth		 3,396.85% 30.13% 245.10% 2,161.49% -89.49% -7.28% -261.51% -206.40% -1,498.62% 184.41%
Invested Capital Growth		 -409.11% 5.84% -3,017.27% -2,490.05% -22.09% 111.41% 92.54% 81.27% 67.54% -4,627.86%
Revenue Q/Q Growth		 -1.67% 0.41% 21.38% 5.29% -1.23% 1.90% 35.07% 8.38% 1.64% 1.27%
EBITDA Q/Q Growth		 -1,916.39% -66.56% 43.53% 35.20% -36.23% -49.99% 14.80% 66.30% 1.62% -34.46%
EBIT Q/Q Growth		 -436.24% -56.57% 38.86% 28.19% -28.09% -40.86% 1.49% 55.55% -6.74% -15.49%
NOPAT Q/Q Growth		 -402.56% -55.96% 37.65% 27.18% -25.77% -40.86% 1.93% 55.28% -6.20% -15.49%
Net Income Q/Q Growth		 -247.56% -41.61% 34.43% 23.75% -23.10% -34.65% 1.39% 48.46% -10.11% -17.54%
EPS Q/Q Growth		 -266.67% -45.45% 37.50% 25.00% -26.67% -31.58% 0.00% 48.00% -7.69% -7.14%
Operating Cash Flow Q/Q Growth		 915.26% -241.99% 157.02% -56.32% -83.88% -3,228.60% 96.67% 477.19% 11.31% -133.26%
Free Cash Flow Firm Q/Q Growth		 1,522.83% -143.70% 306.85% 60.29% -92.74% -545.89% -211.43% -5.59% 4.61% 126.91%
Invested Capital Q/Q Growth		 -2,304.45% 93.06% -998.80% -41.23% -13.34% 100.65% -819.04% -254.44% -96.37% 9.53%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -7.85% -13.02% -6.16% -3.79% -5.23% -7.70% -5.50% -1.71% -1.66% -2.20%
Operating Margin		 -9.27% -14.40% -7.40% -5.12% -6.52% -9.01% -6.54% -2.70% -2.82% -3.22%
EBIT Margin		 -9.24% -14.40% -7.37% -5.02% -6.52% -9.01% -6.55% -2.68% -2.82% -3.22%
Profit (Net Income) Margin		 -11.17% -15.75% -8.51% -6.16% -7.68% -10.15% -7.41% -3.52% -3.82% -4.43%
Tax Burden Percent		 100.42% 100.30% 100.00% 100.00% 100.00% 99.95% 100.00% 100.09% 99.97% 100.02%
Interest Burden Percent		 120.44% 109.05% 115.51% 122.65% 117.88% 112.75% 113.19% 131.12% 135.42% 137.76%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -47.05% -54.88% -56.53% -64.62% -68.41% -74.58% -88.42% -91.03% -94.51% -98.89%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -9,369.88% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -17.65% -32.66% -15.98% -11.25% -14.48% -26.80% -18.89% -7.99% -9.51% -12.65%
Return on Assets (ROA)		 -21.34% -35.73% -18.46% -13.80% -17.06% -30.20% -21.38% -10.49% -12.88% -17.43%
Return on Common Equity (ROCE)		 -47.05% -54.76% -56.41% -64.48% -68.24% -74.14% -87.88% -90.43% -93.84% -98.04%
Return on Equity Simple (ROE_SIMPLE)		 -51.62% 0.00% -65.61% -77.68% -83.78% 0.00% -120.20% -123.59% -125.92% 0.00%
Net Operating Profit after Tax (NOPAT)		 -23 -36 -23 -17 -21 -29 -29 -13 -14 -16
NOPAT Margin		 -6.49% -10.08% -5.18% -3.58% -4.56% -6.30% -4.58% -1.89% -1.97% -2.25%
Net Nonoperating Expense Percent (NNEP)		 -4.45% -7.27% -4.69% -3.64% -3.75% -8.82% -7.63% -4.38% -4.88% -9.98%
Return On Investment Capital (ROIC_SIMPLE)		 - -9.11% - - - -9.17% - - - -3.74%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 21.22% 23.00% 16.03% 15.18% 18.19% 17.99% 14.40% 12.90% 13.12% 14.56%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 109.27% 114.40% 107.40% 105.12% 106.52% 109.01% 106.54% 102.70% 102.82% 103.22%
Earnings before Interest and Taxes (EBIT)		 -33 -52 -32 -23 -30 -42 -41 -18 -20 -23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -28 -47 -27 -18 -24 -36 -35 -12 -11 -15
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 8.15 9.25 5.35 5.16 6.94 10.37 7.16 12.09 19.74 21.60
Price to Tangible Book Value (P/TBV)		 9.45 11.13 6.52 6.38 8.81 13.93 10.32 17.87 30.08 35.66
Price to Revenue (P/Rev)		 1.62 1.54 0.78 0.67 0.76 0.89 0.47 0.67 0.92 0.80
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 1,381.12 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 1.32 1.36 0.57 0.45 0.56 0.81 0.40 0.60 0.85 0.74
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 24.56 0.00 16.87 9.32 0.00 0.00 0.00 0.00 0.00 57.76
Enterprise Value to Free Cash Flow (EV/FCFF)		 74.86 0.00 71.35 18.09 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.59 0.67 0.72 0.76 0.85 1.02 1.23 1.70 1.83 3.18
Long-Term Debt to Equity		 0.59 0.67 0.72 0.76 0.85 1.02 1.23 1.70 1.82 3.18
Financial Leverage		 -1.27 -1.04 -1.20 -1.30 -1.65 -1.02 -1.31 -1.51 -1.71 -1.18
Leverage Ratio		 2.40 2.32 2.72 2.87 3.35 3.08 3.92 4.46 4.79 5.30
Compound Leverage Factor		 2.89 2.53 3.15 3.52 3.95 3.48 4.44 5.85 6.49 7.31
Debt to Total Capital		 37.12% 40.21% 41.84% 43.32% 46.01% 50.58% 55.10% 62.92% 64.71% 76.10%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.49% 0.00%
Long-Term Debt to Total Capital		 37.12% 40.21% 41.84% 43.32% 46.01% 50.58% 55.10% 62.92% 64.22% 76.10%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.29% 0.29% 0.30% 0.31% 0.35% 0.37% 0.32% 0.33% 0.26%
Common Equity to Total Capital		 62.88% 59.50% 57.87% 56.37% 53.67% 49.06% 44.53% 36.76% 34.96% 23.64%
Debt to EBITDA		 -1.60 -1.47 -1.54 -1.34 -1.39 -1.54 -1.39 -1.91 -2.15 -4.39
Net Debt to EBITDA		 4.06 2.27 3.12 2.95 3.05 1.50 1.20 1.37 1.72 2.04
Long-Term Debt to EBITDA		 -1.60 -1.47 -1.54 -1.34 -1.39 -1.54 -1.39 -1.91 -2.14 -4.39
Debt to NOPAT		 -1.91 -1.79 -1.85 -1.63 -1.67 -1.81 -1.70 -2.31 -2.50 -4.52
Net Debt to NOPAT		 4.84 2.76 3.74 3.59 3.66 1.75 1.46 1.66 2.00 2.10
Long-Term Debt to NOPAT		 -1.91 -1.79 -1.85 -1.63 -1.67 -1.81 -1.70 -2.31 -2.49 -4.52
Altman Z-Score		 3.58 4.32 2.25 2.12 2.34 3.46 2.40 3.07 4.22 3.93
Noncontrolling Interest Sharing Ratio		 0.00% 0.22% 0.22% 0.22% 0.24% 0.58% 0.62% 0.66% 0.71% 0.86%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 2.03 2.37 1.79 1.70 1.63 1.84 1.57 1.61 1.60 1.88
Quick Ratio		 1.93 2.18 1.64 1.51 1.51 1.67 1.41 1.47 1.45 1.78
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 85 -37 77 123 8.91 -40 -124 -131 -125 34
Operating Cash Flow to CapEx		 1,342.87% -1,841.16% 1,168.29% 434.31% 62.72% -1,769.05% -56.09% 200.54% 282.22% -93.83%
Free Cash Flow to Firm to Interest Expense		 12.47 -7.73 15.27 23.35 1.63 -7.25 -22.81 -22.97 -17.97 3.94
Operating Cash Flow to Interest Expense		 15.46 -31.14 16.96 7.07 1.10 -34.18 -1.15 4.13 3.78 -1.02
Operating Cash Flow Less CapEx to Interest Expense		 14.31 -32.83 15.51 5.44 -0.65 -36.12 -3.20 2.07 2.44 -2.11
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 1.91 2.27 2.17 2.24 2.22 2.98 2.89 2.98 3.37 3.94
Accounts Receivable Turnover		 20.17 18.95 14.56 17.37 17.76 17.15 13.87 16.40 20.20 19.76
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 40.86 42.48 42.82 42.48 41.58 40.95 41.58 42.33 44.12 45.42
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 18.09 19.27 25.06 21.01 20.56 21.28 26.32 22.25 18.07 18.47
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 18.09 19.27 25.06 21.01 20.56 21.28 26.32 22.25 18.07 18.47
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 -135 -9.35 -103 -145 -164 1.07 -7.67 -27 -53 -48
Invested Capital Turnover		 -17.02 -148.85 -28.83 -21.56 -11.51 -440.54 -36.49 -25.93 -22.67 -114.56
Increase / (Decrease) in Invested Capital		 -108 0.58 -99 -139 -30 10 95 118 111 -49
Enterprise Value (EV)		 1,810 1,955 866 728 955 1,472 799 1,344 2,093 2,008
Market Capitalization		 2,217 2,202 1,191 1,083 1,308 1,628 938 1,495 2,261 2,157
Book Value per Share		 $1.45 $1.27 $1.19 $1.11 $1.00 $0.83 $0.69 $0.65 $0.60 $0.52
Tangible Book Value per Share		 $1.25 $1.06 $0.98 $0.90 $0.79 $0.62 $0.48 $0.44 $0.39 $0.32
Total Capital		 433 400 385 372 351 320 294 337 328 422
Total Debt		 161 161 161 161 162 162 162 212 212 321
Total Long-Term Debt		 161 161 161 161 162 162 162 212 210 321
Net Debt		 -407 -249 -327 -356 -354 -157 -140 -152 -169 -149
Capital Expenditures (CapEx)		 7.83 8.11 7.29 8.56 9.55 11 11 12 9.28 9.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -216 -95 -191 -236 -259 -98 -112 -136 -164 -161
Debt-free Net Working Capital (DFNWC)		 352 315 297 282 257 221 190 228 217 310
Net Working Capital (NWC)		 352 315 297 282 257 221 190 228 216 310
Net Nonoperating Expense (NNE)		 17 21 15 12 14 18 18 11 13 15
Net Nonoperating Obligations (NNO)		 -407 -249 -327 -356 -354 -157 -140 -152 -169 -149
Total Depreciation and Amortization (D&A)		 4.99 4.99 5.29 5.69 5.86 6.08 6.55 6.63 8.05 7.12
Debt-free, Cash-free Net Working Capital to Revenue		 -15.73% -6.62% -12.50% -14.52% -15.05% -5.39% -5.55% -6.10% -6.64% -5.95%
Debt-free Net Working Capital to Revenue		 25.67% 21.94% 19.42% 17.35% 14.92% 12.09% 9.43% 10.20% 8.80% 11.46%
Net Working Capital to Revenue		 25.67% 21.94% 19.42% 17.35% 14.92% 12.09% 9.43% 10.20% 8.73% 11.46%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.22) ($0.32) ($0.20) ($0.15) ($0.19) ($0.25) ($0.25) ($0.13) ($0.14) ($0.15)
Adjusted Weighted Average Basic Shares Outstanding		 187.26M 181.21M 188.38M 188.40M 187.33M 186.21M 189.01M 190.89M 191.36M 190.79M
Adjusted Diluted Earnings per Share		 ($0.22) ($0.32) ($0.20) ($0.15) ($0.19) ($0.25) ($0.25) ($0.13) ($0.14) ($0.15)
Adjusted Weighted Average Diluted Shares Outstanding		 187.26M 181.21M 188.38M 188.40M 187.33M 186.21M 189.01M 190.89M 191.36M 190.79M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 182.12M 181.21M 183.11M 185.99M 0.00 188.98M 191.20M 191.30M 191.70M 191.83M
Normalized Net Operating Profit after Tax (NOPAT)		 -23 -36 -23 -17 -21 -29 -29 -13 -14 -16
Normalized NOPAT Margin		 -6.49% -10.08% -5.18% -3.58% -4.56% -6.30% -4.58% -1.89% -1.97% -2.25%
Pre Tax Income Margin		 -11.12% -15.71% -8.51% -6.16% -7.68% -10.15% -7.41% -3.52% -3.82% -4.43%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -4.89 -10.87 -6.45 -4.41 -5.44 -7.64 -7.58 -3.21 -2.81 -2.65
NOPAT to Interest Expense		 -3.44 -7.61 -4.53 -3.15 -3.81 -5.35 -5.30 -2.26 -1.97 -1.85
EBIT Less CapEx to Interest Expense		 -6.04 -12.56 -7.90 -6.04 -7.19 -9.58 -9.63 -5.28 -4.15 -3.74
NOPAT Less CapEx to Interest Expense		 -4.59 -9.30 -5.98 -4.77 -5.56 -7.28 -7.35 -4.32 -3.31 -2.94
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 -0.08% -0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.08% -0.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Alignment Healthcare's Financials

When does Alignment Healthcare's financial year end?

According to the most recent income statement we have on file, Alignment Healthcare's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Alignment Healthcare's net income changed over the last 5 years?

Alignment Healthcare's net income appears to be on an upward trend, with a most recent value of -$128.07 million in 2024, rising from -$44.73 million in 2019. The previous period was -$148.17 million in 2023.

What is Alignment Healthcare's operating income?
Alignment Healthcare's total operating income in 2024 was -$101.56 million, based on the following breakdown:
  • Total Gross Profit: $2.70 billion
  • Total Operating Expenses: $2.81 billion
How has Alignment Healthcare revenue changed over the last 5 years?

Over the last 5 years, Alignment Healthcare's total revenue changed from $756.96 million in 2019 to $2.70 billion in 2024, a change of 257.2%.

How much debt does Alignment Healthcare have?

Alignment Healthcare's total liabilities were at $681.11 million at the end of 2024, a 57.0% increase from 2023, and a 121.2% increase since 2020.

How much cash does Alignment Healthcare have?

In the past 4 years, Alignment Healthcare's cash and equivalents has ranged from $202.90 million in 2023 to $466.60 million in 2021, and is currently $432.86 million as of their latest financial filing in 2024.

How has Alignment Healthcare's book value per share changed over the last 5 years?

Over the last 5 years, Alignment Healthcare's book value per share changed from 0.00 in 2019 to 0.52 in 2024, a change of 52.1%.

Remove Ads

Related Companies

This page (NASDAQ:ALHC) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored
The Crypto Market is About to Change Lives
I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...
Crypto 101 Media | Sponsored
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...
Paradigm Press | Sponsored
Two Unmistakable Patterns Return…
The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...
Golden Portfolio | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored